Search This Blog

Thursday, July 25, 2019

ResMed EPS beats by $0.03, beats on revenue

ResMed (NYSE:RMD): Q4 Non-GAAP EPS of $0.95 beats by $0.03; GAAP EPS of $0.48 misses by $0.34.
Revenue of $705M (+13.1% Y/Y) beats by $3.44M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)